OR WAIT null SECS
June 22, 2022
Kindeva’s acquisition of iPharma will increase the company’s inhalation formulation outsourcing capabilities.
June 17, 2022
Aptamer Group has signed a deal with Flip Gene Therapeutics to support the development of inducible gene therapies.
Boehringer Ingelheim has signed an option to acquire Trutino Biosciences.
June 09, 2022
Roche has received approval from the European Commission for Lunsumio (mosunetuzumab), the first CD20xCD3 T-cell engaging bispecific antibody for treating follicular lymphoma.
June 08, 2022
The acquisition grants Bristol Myers Squibb access to the company's oncology pipeline and lead candidate, repotrectinib.
June 07, 2022
Sanofi will grant Regeneron worldwide exclusive license rights to Libtayo, a treatment for non-small cell lung cancer.
June 03, 2022
Astellas and GO Therapeutics will work together to develop novel antibodies for immuno-oncology.
Cambrex’s acquisition of Q1 Scientific expands the company’s storage services in the European market.
June 02, 2022
Is AI a panacea for pharma’s productivity gap?
Precompetitive consortiums seek solutions to industry-wide challenges.